Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Employees Cystic Fibrosis Foundation Gentiana S Arovas

Gentiana S Arovas

Highest compensated employee

Managing Director, Investments Operations at Cystic Fibrosis Foundation

Fiscal year ended December 31, 2024. Published on January 25, 2026.

$819,659
2024

Total compensation

Gentiana S Arovas has been listed as an employee of Cystic Fibrosis Foundation in Form 990 filings since fiscal year 2021. Total compensation for Gentiana S Arovas has increased by 40.2% from 2021 to 2024.

Annual compensation details

$819,659
+12%
Managing Director, Investments Operations
2024
$643k
40 hrs/wk
$178k
--
$731,737
Managing Director, Investments
2023
$542k
40 hrs/wk
$191k
--
$584,594
Investment Operations Director
2021
$468k
40 hrs/wk
$118k
--

Total compensation by year

Compare the compensation of Gentiana S Arovas to:

Revisions to this profile

January 25, 2026:
2024 Cystic Fibrosis Foundation 990 published
January 25, 2026:
2023 Cystic Fibrosis Foundation 990 published
January 25, 2026:
2021 Cystic Fibrosis Foundation 990 published

Get an email update when compensation for Gentiana S Arovas is updated

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →
2024

Other employees at Cystic Fibrosis Foundation

John C Mahler Jr, M.D.
Chief Investment Officer
$1,942,627
$1,866,868 No related comp$75,759
Earl A Lee
Managing Director, Investments
$1,594,752
$1,226,269 No related comp$368,483
Andrew Lewis
Managing Director, Investments
$1,401,714
$1,363,454 No related comp$38,260
Eric Koehrsen
Managing Director, Investments
$1,280,707
$976,105 No related comp$304,602
Michael P Boyle, M.D.
President and Chief Executive Officer
$1,275,151
$1,054,388 No related comp$220,763
Irena Barisic
Executive Vice President and Chief Operating and Financial Officer
$844,555
$761,939 No related comp$82,616
John P Clancy, M.D.
Senior Vice President, Clinical Research
$765,204
$669,826 No related comp$95,378
Albert Faro, M.D.
Chief Medical Officer Beg. 7/1/2024
$671,590
$571,672 No related comp$99,918
Steven Rowe, M.D.
Executive Vice President, Chief Scientific Officer
$667,206
$534,655 No related comp$132,551